John Baresky

… Healthcare systems are strategically enriching their digital doorstep for consumers and patients … John G. Baresky Health system consolidation across the nation is changing the clinical and commercial landscape of the healthcare industry. The larger healthcare systems grow, the more patients they must attract and retain.

… Intellia Therapeutics is taking charge of advanced genetics … Intellia Therapeutics (NASDAQ: NTLA) and its partner Regeneron are on to something big in genetic sciences and anticipation is building for future breakthroughs. Intellia is a biopharmaceutical research-driven innovator focused on the development of gene-editing therapies to help patients with autoimmune, genetic and oncology healthcare challenges.

… GlaxoSmithKline is selling its consumer products division … John G. Baresky GlaxoSmithKline (GSK) is pulling the trigger on earlier considerations and spinning off its consumer products business unit as a separate company. It has been reported that GSK (NYSE: GSK) had a divestiture of its consumer products portfolio at least as far back as 2018.